HRP20160601T1 - Spirociklički derivati izoksazolina kao antiparazitska sredstva - Google Patents
Spirociklički derivati izoksazolina kao antiparazitska sredstva Download PDFInfo
- Publication number
- HRP20160601T1 HRP20160601T1 HRP20160601TT HRP20160601T HRP20160601T1 HR P20160601 T1 HRP20160601 T1 HR P20160601T1 HR P20160601T T HRP20160601T T HR P20160601TT HR P20160601 T HRP20160601 T HR P20160601T HR P20160601 T1 HRP20160601 T1 HR P20160601T1
- Authority
- HR
- Croatia
- Prior art keywords
- trifluoromethyl
- isobenzofuran
- spiro
- dihydroisoxazol
- azetidin
- Prior art date
Links
- 239000003096 antiparasitic agent Substances 0.000 title 1
- 229940125687 antiparasitic agent Drugs 0.000 title 1
- 150000002547 isoxazolines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 23
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 17
- 150000002367 halogens Chemical class 0.000 claims 16
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 15
- -1 5′-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3′H-spiro[azetidine-3,1′-isobenzofuran ]-1-yl Chemical group 0.000 claims 15
- 125000001424 substituent group Chemical group 0.000 claims 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 13
- 125000004093 cyano group Chemical group *C#N 0.000 claims 12
- 229910052736 halogen Inorganic materials 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 9
- 239000001257 hydrogen Substances 0.000 claims 9
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 9
- 229910003827 NRaRb Inorganic materials 0.000 claims 8
- CKJNUZNMWOVDFN-UHFFFAOYSA-N methanone Chemical compound O=[CH-] CKJNUZNMWOVDFN-UHFFFAOYSA-N 0.000 claims 8
- 125000004043 oxo group Chemical group O=* 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 238000002360 preparation method Methods 0.000 claims 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- FLEFKKUZMDEUIP-QFIPXVFZSA-N 1-[6-[(5s)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3C[C@](ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 FLEFKKUZMDEUIP-QFIPXVFZSA-N 0.000 claims 3
- FLEFKKUZMDEUIP-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 FLEFKKUZMDEUIP-UHFFFAOYSA-N 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 239000000460 chlorine Substances 0.000 claims 3
- XFQOIEVYRDVPHM-JOCHJYFZSA-N 1-[6-[(5r)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfanylethanone Chemical compound C1N(C(=O)CSC)CC21C1=CC=C(C=3C[C@@](ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 XFQOIEVYRDVPHM-JOCHJYFZSA-N 0.000 claims 2
- FLEFKKUZMDEUIP-JOCHJYFZSA-N 1-[6-[(5r)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3C[C@@](ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 FLEFKKUZMDEUIP-JOCHJYFZSA-N 0.000 claims 2
- AIXINBQHGDBJNF-JOCHJYFZSA-N 1-[6-[(5r)-5-(3-chloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3C[C@@](ON=3)(C=3C=C(Cl)C(F)=CC=3)C(F)(F)F)C=C1CO2 AIXINBQHGDBJNF-JOCHJYFZSA-N 0.000 claims 2
- ANGFWLPBWXRLME-JOCHJYFZSA-N 1-[6-[(5r)-5-[3,5-bis(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3C[C@@](ON=3)(C=3C=C(C=C(C=3)C(F)(F)F)C(F)(F)F)C(F)(F)F)C=C1CO2 ANGFWLPBWXRLME-JOCHJYFZSA-N 0.000 claims 2
- XFQOIEVYRDVPHM-QFIPXVFZSA-N 1-[6-[(5s)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfanylethanone Chemical compound C1N(C(=O)CSC)CC21C1=CC=C(C=3C[C@](ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 XFQOIEVYRDVPHM-QFIPXVFZSA-N 0.000 claims 2
- AIXINBQHGDBJNF-QFIPXVFZSA-N 1-[6-[(5s)-5-(3-chloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3C[C@](ON=3)(C=3C=C(Cl)C(F)=CC=3)C(F)(F)F)C=C1CO2 AIXINBQHGDBJNF-QFIPXVFZSA-N 0.000 claims 2
- ANGFWLPBWXRLME-QFIPXVFZSA-N 1-[6-[(5s)-5-[3,5-bis(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3C[C@](ON=3)(C=3C=C(C=C(C=3)C(F)(F)F)C(F)(F)F)C(F)(F)F)C=C1CO2 ANGFWLPBWXRLME-QFIPXVFZSA-N 0.000 claims 2
- NWNDKDNRGRCZBK-DPYUEULQSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-[(r)-methylsulfinyl]ethanone Chemical compound C1N(C(=O)C[S@](=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 NWNDKDNRGRCZBK-DPYUEULQSA-N 0.000 claims 2
- NWNDKDNRGRCZBK-YYFDOOGASA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-[(s)-methylsulfinyl]ethanone Chemical compound C1N(C(=O)C[S@@](=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 NWNDKDNRGRCZBK-YYFDOOGASA-N 0.000 claims 2
- XFQOIEVYRDVPHM-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfanylethanone Chemical compound C1N(C(=O)CSC)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 XFQOIEVYRDVPHM-UHFFFAOYSA-N 0.000 claims 2
- NWNDKDNRGRCZBK-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfinylethanone Chemical compound C1N(C(=O)CS(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 NWNDKDNRGRCZBK-UHFFFAOYSA-N 0.000 claims 2
- AIXINBQHGDBJNF-UHFFFAOYSA-N 1-[6-[5-(3-chloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=CC=3)C(F)(F)F)C=C1CO2 AIXINBQHGDBJNF-UHFFFAOYSA-N 0.000 claims 2
- ANGFWLPBWXRLME-UHFFFAOYSA-N 1-[6-[5-[3,5-bis(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(C=C(C=3)C(F)(F)F)C(F)(F)F)C(F)(F)F)C=C1CO2 ANGFWLPBWXRLME-UHFFFAOYSA-N 0.000 claims 2
- VUWIIEVQYCGTAH-JOCHJYFZSA-N 2-methylsulfonyl-1-[6-[(5r)-5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]ethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3C[C@@](ON=3)(C=3C=C(C=CC=3)C(F)(F)F)C(F)(F)F)C=C1CO2 VUWIIEVQYCGTAH-JOCHJYFZSA-N 0.000 claims 2
- VUWIIEVQYCGTAH-QFIPXVFZSA-N 2-methylsulfonyl-1-[6-[(5s)-5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]ethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3C[C@](ON=3)(C=3C=C(C=CC=3)C(F)(F)F)C(F)(F)F)C=C1CO2 VUWIIEVQYCGTAH-QFIPXVFZSA-N 0.000 claims 2
- VUWIIEVQYCGTAH-UHFFFAOYSA-N 2-methylsulfonyl-1-[6-[5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]ethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(C=CC=3)C(F)(F)F)C(F)(F)F)C=C1CO2 VUWIIEVQYCGTAH-UHFFFAOYSA-N 0.000 claims 2
- 239000005660 Abamectin Substances 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- 239000005907 Indoxacarb Substances 0.000 claims 2
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 claims 2
- AQXXZDYPVDOQEE-MXDQRGINSA-N Pyrantel pamoate Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1.C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 AQXXZDYPVDOQEE-MXDQRGINSA-N 0.000 claims 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 claims 2
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- 238000009833 condensation Methods 0.000 claims 2
- 230000005494 condensation Effects 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 239000011737 fluorine Substances 0.000 claims 2
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 claims 2
- 229960001614 levamisole Drugs 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 claims 2
- CKVMAPHTVCTEMM-ALPQRHTBSA-N milbemycin oxime Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\2)O)C[C@H]4C1.C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\1)O)C[C@H]4C2 CKVMAPHTVCTEMM-ALPQRHTBSA-N 0.000 claims 2
- 229940099245 milbemycin oxime Drugs 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 claims 2
- 229960004816 moxidectin Drugs 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 229960000996 pyrantel pamoate Drugs 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical class Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 claims 1
- ULUOLNRRFGCHQM-JGCGQSQUSA-N 1'-benzhydryl-6-[(5r)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine] Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1[C@]1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(C=4C=CC=CC=4)C=4C=CC=CC=4)OC3)=CC=2)C1 ULUOLNRRFGCHQM-JGCGQSQUSA-N 0.000 claims 1
- ULUOLNRRFGCHQM-YTTGMZPUSA-N 1'-benzhydryl-6-[(5s)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine] Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1[C@@]1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(C=4C=CC=CC=4)C=4C=CC=CC=4)OC3)=CC=2)C1 ULUOLNRRFGCHQM-YTTGMZPUSA-N 0.000 claims 1
- ULUOLNRRFGCHQM-UHFFFAOYSA-N 1'-benzhydryl-6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine] Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1C1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(C=4C=CC=CC=4)C=4C=CC=CC=4)OC3)=CC=2)C1 ULUOLNRRFGCHQM-UHFFFAOYSA-N 0.000 claims 1
- WZBRBYGZBDBNHF-UHFFFAOYSA-N 1'-benzhydryl-6-bromospiro[1h-2-benzofuran-3,3'-azetidine] Chemical compound C=1C(Br)=CC=C2C=1COC2(C1)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 WZBRBYGZBDBNHF-UHFFFAOYSA-N 0.000 claims 1
- YPCUIFDRGBCTSC-UHFFFAOYSA-N 1-(1'-benzhydrylspiro[3h-2-benzofuran-1,3'-azetidine]-5-yl)ethanone Chemical compound C=1C(C(=O)C)=CC=C2C=1COC2(C1)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 YPCUIFDRGBCTSC-UHFFFAOYSA-N 0.000 claims 1
- DSPTWTWGSSFAOJ-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2,2-dimethylpropan-1-one Chemical compound C1N(C(=O)C(C)(C)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 DSPTWTWGSSFAOJ-UHFFFAOYSA-N 0.000 claims 1
- IAPFTFFEACOUHY-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-(3-methylpyrazol-1-yl)ethanone Chemical compound N1=C(C)C=CN1CC(=O)N1CC2(C3=CC=C(C=C3CO2)C=2CC(ON=2)(C=2C=C(Cl)C(F)=C(Cl)C=2)C(F)(F)F)C1 IAPFTFFEACOUHY-UHFFFAOYSA-N 0.000 claims 1
- MHWFMDKTTPEXER-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-(trifluoromethylsulfanyl)ethanone Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1C1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(=O)CSC(F)(F)F)OC3)=CC=2)C1 MHWFMDKTTPEXER-UHFFFAOYSA-N 0.000 claims 1
- UVLHSRHUGANNFW-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-hydroxy-2-methylpropan-1-one Chemical compound C1N(C(=O)C(C)(O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 UVLHSRHUGANNFW-UHFFFAOYSA-N 0.000 claims 1
- ODFUPHRWJSKJPR-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-hydroxyethanone Chemical compound C1N(C(=O)CO)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 ODFUPHRWJSKJPR-UHFFFAOYSA-N 0.000 claims 1
- UMCLDHWJNSMTFI-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylpropan-1-one Chemical compound C1N(C(=O)C(C)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 UMCLDHWJNSMTFI-UHFFFAOYSA-N 0.000 claims 1
- LDGYKPIXMSKOSU-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-pyrazol-1-ylethanone Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1C1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(=O)CN4N=CC=C4)OC3)=CC=2)C1 LDGYKPIXMSKOSU-UHFFFAOYSA-N 0.000 claims 1
- UMHXXOPBAGIMEL-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-3-hydroxy-2-methylpropan-1-one Chemical compound C1N(C(=O)C(CO)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 UMHXXOPBAGIMEL-UHFFFAOYSA-N 0.000 claims 1
- YWXLNMWPXFOWOK-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-3-hydroxybutan-1-one Chemical compound C1N(C(=O)CC(O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 YWXLNMWPXFOWOK-UHFFFAOYSA-N 0.000 claims 1
- IFFZOVIWDNUNBS-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-3-methylbutan-1-one Chemical compound C1N(C(=O)CC(C)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 IFFZOVIWDNUNBS-UHFFFAOYSA-N 0.000 claims 1
- MAYWQOHLKGLQJW-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]butan-1-one Chemical compound C1N(C(=O)CCC)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 MAYWQOHLKGLQJW-UHFFFAOYSA-N 0.000 claims 1
- XOMLTSNTYIXJST-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]ethanone Chemical compound C1N(C(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 XOMLTSNTYIXJST-UHFFFAOYSA-N 0.000 claims 1
- YYNGVGQJJABMAZ-UHFFFAOYSA-N 1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]propan-1-one Chemical compound C1N(C(=O)CC)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 YYNGVGQJJABMAZ-UHFFFAOYSA-N 0.000 claims 1
- IMTGOCLPUMALIP-UHFFFAOYSA-N 1-[6-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C=C(Cl)C=3)C(F)(F)F)C=C1CO2 IMTGOCLPUMALIP-UHFFFAOYSA-N 0.000 claims 1
- VBXZGVDSHYHKGO-UHFFFAOYSA-N 1-[6-[5-(3-bromo-5-chlorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Br)C=C(Cl)C=3)C(F)(F)F)C=C1CO2 VBXZGVDSHYHKGO-UHFFFAOYSA-N 0.000 claims 1
- OSWZYTMLJACSNN-UHFFFAOYSA-N 1-[6-[5-(3-chloro-5-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C=C(F)C=3)C(F)(F)F)C=C1CO2 OSWZYTMLJACSNN-UHFFFAOYSA-N 0.000 claims 1
- AGVAIAZEOMFILN-UHFFFAOYSA-N 1-[6-[5-(4-bromo-3,5-dichlorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(Br)=C(Cl)C=3)C(F)(F)F)C=C1CO2 AGVAIAZEOMFILN-UHFFFAOYSA-N 0.000 claims 1
- FXHHTCGMOVWSHU-UHFFFAOYSA-N 1-[6-[5-[3,4-dichloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(C(Cl)=C(Cl)C=3)C(F)(F)F)C(F)(F)F)C=C1CO2 FXHHTCGMOVWSHU-UHFFFAOYSA-N 0.000 claims 1
- HLLNFTHFKKIKJD-UHFFFAOYSA-N 1-[6-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(C=C(Cl)C=3)C(F)(F)F)C(F)(F)F)C=C1CO2 HLLNFTHFKKIKJD-UHFFFAOYSA-N 0.000 claims 1
- LUMKJPVWLZOGKI-UHFFFAOYSA-N 1-[6-[5-[4-chloro-3,5-bis(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(C(Cl)=C(C=3)C(F)(F)F)C(F)(F)F)C(F)(F)F)C=C1CO2 LUMKJPVWLZOGKI-UHFFFAOYSA-N 0.000 claims 1
- AVUDXLOVIBJFQA-UHFFFAOYSA-N 1-benzhydrylazetidin-3-one Chemical compound C1C(=O)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 AVUDXLOVIBJFQA-UHFFFAOYSA-N 0.000 claims 1
- NVEPPWDVLBMNMB-SNAWJCMRSA-N 1-methyl-2-[(e)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound CN1CCCN=C1\C=C\C1=C(C)C=CS1 NVEPPWDVLBMNMB-SNAWJCMRSA-N 0.000 claims 1
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 claims 1
- KZJRKRQSDZGHEC-UHFFFAOYSA-N 2,2,2-trifluoro-1-phenylethanone Chemical class FC(F)(F)C(=O)C1=CC=CC=C1 KZJRKRQSDZGHEC-UHFFFAOYSA-N 0.000 claims 1
- FXJRDUKXWHFPND-NSHDSACASA-N 2-[(1s)-1-(2,3-dimethylphenyl)ethyl]-1h-imidazole Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=NC=CN1 FXJRDUKXWHFPND-NSHDSACASA-N 0.000 claims 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims 1
- FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 claims 1
- YQGNJRMESNQQEB-UHFFFAOYSA-N 2-cyclopropyl-1-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]ethanone Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1C1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(=O)CC4CC4)OC3)=CC=2)C1 YQGNJRMESNQQEB-UHFFFAOYSA-N 0.000 claims 1
- ZAWXPDROSUZCTP-UHFFFAOYSA-N 2-methylsulfonyl-1-[6-[5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]ethanone Chemical compound C1N(C(=O)CS(=O)(=O)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(Cl)=C(Cl)C=3)C(F)(F)F)C=C1CO2 ZAWXPDROSUZCTP-UHFFFAOYSA-N 0.000 claims 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims 1
- JAARRMAXWFHZJM-UHFFFAOYSA-N 3-oxoazetidine-1-carboxylic acid Chemical class OC(=O)N1CC(=O)C1 JAARRMAXWFHZJM-UHFFFAOYSA-N 0.000 claims 1
- QOVTVIYTBRHADL-UHFFFAOYSA-N 4-amino-6-(1,2,2-trichloroethenyl)benzene-1,3-disulfonamide Chemical compound NC1=CC(C(Cl)=C(Cl)Cl)=C(S(N)(=O)=O)C=C1S(N)(=O)=O QOVTVIYTBRHADL-UHFFFAOYSA-N 0.000 claims 1
- OVMPAVCSOVHNOB-UHFFFAOYSA-N 4-bromo-2-(chloromethyl)-1-iodobenzene Chemical group ClCC1=CC(Br)=CC=C1I OVMPAVCSOVHNOB-UHFFFAOYSA-N 0.000 claims 1
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 claims 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 claims 1
- NQPDXQQQCQDHHW-UHFFFAOYSA-N 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole Chemical compound ClC=1C=C2NC(SC)=NC2=CC=1OC1=CC=CC(Cl)=C1Cl NQPDXQQQCQDHHW-UHFFFAOYSA-N 0.000 claims 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims 1
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 claims 1
- 239000005886 Chlorantraniliprole Substances 0.000 claims 1
- 235000001258 Cinchona calisaya Nutrition 0.000 claims 1
- 239000005894 Emamectin Substances 0.000 claims 1
- 239000005899 Fipronil Substances 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 239000007818 Grignard reagent Substances 0.000 claims 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims 1
- 239000005906 Imidacloprid Substances 0.000 claims 1
- 206010061217 Infestation Diseases 0.000 claims 1
- 239000005912 Lufenuron Substances 0.000 claims 1
- 239000005914 Metaflumizone Substances 0.000 claims 1
- MIFOMMKAVSCNKQ-HWIUFGAZSA-N Metaflumizone Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)N\N=C(C=1C=C(C=CC=1)C(F)(F)F)\CC1=CC=C(C#N)C=C1 MIFOMMKAVSCNKQ-HWIUFGAZSA-N 0.000 claims 1
- YRWLZFXJFBZBEY-UHFFFAOYSA-N N-(6-butyl-1H-benzimidazol-2-yl)carbamic acid methyl ester Chemical compound CCCCC1=CC=C2N=C(NC(=O)OC)NC2=C1 YRWLZFXJFBZBEY-UHFFFAOYSA-N 0.000 claims 1
- RAOCRURYZCVHMG-UHFFFAOYSA-N N-(6-propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester Chemical compound CCCOC1=CC=C2N=C(NC(=O)OC)NC2=C1 RAOCRURYZCVHMG-UHFFFAOYSA-N 0.000 claims 1
- JMPFSEBWVLAJKM-UHFFFAOYSA-N N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide Chemical compound ClC=1C=C(NC(=O)C=2C(=C(I)C=C(I)C=2)O)C(C)=CC=1C(C#N)C1=CC=C(Cl)C=C1 JMPFSEBWVLAJKM-UHFFFAOYSA-N 0.000 claims 1
- 208000030852 Parasitic disease Diseases 0.000 claims 1
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 claims 1
- 239000005926 Pyridalyl Substances 0.000 claims 1
- 239000005929 Spinetoram Substances 0.000 claims 1
- GOENIMGKWNZVDA-OAMCMWGQSA-N Spinetoram Chemical compound CO[C@@H]1[C@H](OCC)[C@@H](OC)[C@H](C)O[C@H]1OC1C[C@H]2[C@@H]3C=C4C(=O)[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@H](CC5)N(C)C)CCC[C@H](CC)OC(=O)CC4[C@@H]3CC[C@@H]2C1 GOENIMGKWNZVDA-OAMCMWGQSA-N 0.000 claims 1
- 239000005930 Spinosad Substances 0.000 claims 1
- 239000005665 Spiromesifen Substances 0.000 claims 1
- 239000005937 Tebufenozide Substances 0.000 claims 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims 1
- QVOXVZKOMZDGFK-UHFFFAOYSA-N [6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-(1-hydroxycyclopropyl)methanone Chemical compound C1C2(C3=CC=C(C=C3CO2)C=2CC(ON=2)(C=2C=C(Cl)C(F)=C(Cl)C=2)C(F)(F)F)CN1C(=O)C1(O)CC1 QVOXVZKOMZDGFK-UHFFFAOYSA-N 0.000 claims 1
- DVSZWSAMFFOPLD-UHFFFAOYSA-N [6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-(thietan-3-yl)methanone Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1C1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(=O)C4CSC4)OC3)=CC=2)C1 DVSZWSAMFFOPLD-UHFFFAOYSA-N 0.000 claims 1
- BOUKQUZBIVLADH-UHFFFAOYSA-N [6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-[1-(trifluoromethyl)cyclopropyl]methanone Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1C1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(=O)C4(CC4)C(F)(F)F)OC3)=CC=2)C1 BOUKQUZBIVLADH-UHFFFAOYSA-N 0.000 claims 1
- 229950008167 abamectin Drugs 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229960002669 albendazole Drugs 0.000 claims 1
- HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 229960002587 amitraz Drugs 0.000 claims 1
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 claims 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 239000002585 base Substances 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 229960003475 cambendazole Drugs 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 claims 1
- 229960000275 clorsulon Drugs 0.000 claims 1
- 229950004178 closantel Drugs 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- DBMQXBQCOXIOSJ-UHFFFAOYSA-N cyclobutyl-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]methanone Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1C1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(=O)C4CCC4)OC3)=CC=2)C1 DBMQXBQCOXIOSJ-UHFFFAOYSA-N 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- IEAUXDKEDRFAAH-UHFFFAOYSA-N cyclopropyl-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]methanone Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1C1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(=O)C4CC4)OC3)=CC=2)C1 IEAUXDKEDRFAAH-UHFFFAOYSA-N 0.000 claims 1
- 229950003960 demiditraz Drugs 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 claims 1
- 229960003997 doramectin Drugs 0.000 claims 1
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 claims 1
- GCKZANITAMOIAR-XWVCPFKXSA-N dsstox_cid_14566 Chemical compound [O-]C(=O)C1=CC=CC=C1.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H]([NH2+]C)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 GCKZANITAMOIAR-XWVCPFKXSA-N 0.000 claims 1
- WPNHOHPRXXCPRA-TVXIRPTOSA-N eprinomectin Chemical compound O1[C@@H](C)[C@@H](NC(C)=O)[C@H](OC)C[C@@H]1O[C@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C\C=C/[C@@H]2C)\C)O[C@H]1C WPNHOHPRXXCPRA-TVXIRPTOSA-N 0.000 claims 1
- 229960002346 eprinomectin Drugs 0.000 claims 1
- 229960005362 epsiprantel Drugs 0.000 claims 1
- LGUDKOQUWIHXOV-UHFFFAOYSA-N epsiprantel Chemical compound C1C(C2=CC=CC=C2CCC2)N2C(=O)CN1C(=O)C1CCCCC1 LGUDKOQUWIHXOV-UHFFFAOYSA-N 0.000 claims 1
- 229960005473 fenbendazole Drugs 0.000 claims 1
- IRHZVMHXVHSMKB-UHFFFAOYSA-N fenbendazole Chemical compound [CH]1C2=NC(NC(=O)OC)=NC2=CC=C1SC1=CC=CC=C1 IRHZVMHXVHSMKB-UHFFFAOYSA-N 0.000 claims 1
- 229940013764 fipronil Drugs 0.000 claims 1
- CPEUVMUXAHMANV-UHFFFAOYSA-N flubendazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=C(F)C=C1 CPEUVMUXAHMANV-UHFFFAOYSA-N 0.000 claims 1
- 229960004500 flubendazole Drugs 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 150000004795 grignard reagents Chemical class 0.000 claims 1
- FYQGBXGJFWXIPP-UHFFFAOYSA-N hydroprene Chemical compound CCOC(=O)C=C(C)C=CCC(C)CCCC(C)C FYQGBXGJFWXIPP-UHFFFAOYSA-N 0.000 claims 1
- 229930000073 hydroprene Natural products 0.000 claims 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 claims 1
- 229940056881 imidacloprid Drugs 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 229960002418 ivermectin Drugs 0.000 claims 1
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 claims 1
- 229960000521 lufenuron Drugs 0.000 claims 1
- 229960003439 mebendazole Drugs 0.000 claims 1
- BAXLBXFAUKGCDY-UHFFFAOYSA-N mebendazole Chemical compound [CH]1C2=NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=CC=C1 BAXLBXFAUKGCDY-UHFFFAOYSA-N 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 238000006263 metalation reaction Methods 0.000 claims 1
- 229950003442 methoprene Drugs 0.000 claims 1
- 229930002897 methoprene Natural products 0.000 claims 1
- YMEHWISYYMKMFO-WOMRJYOTSA-N methyl N-[(12E,15S)-15-[(4S)-4-(3-chlorophenyl)-2-oxopiperidin-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate Chemical compound COC(=O)Nc1ccc2-c3cnc([nH]3)[C@H](C\C=C\CCC(=O)Nc2c1)N1CC[C@@H](CC1=O)c1cccc(Cl)c1 YMEHWISYYMKMFO-WOMRJYOTSA-N 0.000 claims 1
- 229960005121 morantel Drugs 0.000 claims 1
- OBKLMNQBLOHWRX-UHFFFAOYSA-N n-[2-[6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-oxoethyl]formamide Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1C1(C(F)(F)F)ON=C(C=2C=C3C(C4(CN(C4)C(=O)CNC=O)OC3)=CC=2)C1 OBKLMNQBLOHWRX-UHFFFAOYSA-N 0.000 claims 1
- 229950009729 nemadectin Drugs 0.000 claims 1
- YNFMRVVYUVPIAN-AQUURSMBSA-N nemadectin Chemical compound C1[C@H](O)[C@H](C)[C@@H](C(/C)=C/C(C)C)O[C@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YNFMRVVYUVPIAN-AQUURSMBSA-N 0.000 claims 1
- YNFMRVVYUVPIAN-UHFFFAOYSA-N nemadectin alpha Natural products C1C(O)C(C)C(C(C)=CC(C)C)OC11OC(CC=C(C)CC(C)C=CC=C2C3(C(C(=O)O4)C=C(C)C(O)C3OC2)O)CC4C1 YNFMRVVYUVPIAN-UHFFFAOYSA-N 0.000 claims 1
- 229960001920 niclosamide Drugs 0.000 claims 1
- RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 claims 1
- 238000005580 one pot reaction Methods 0.000 claims 1
- VRYKTHBAWRESFI-VOTSOKGWSA-N oxantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CC(O)=C1 VRYKTHBAWRESFI-VOTSOKGWSA-N 0.000 claims 1
- 229960000535 oxantel Drugs 0.000 claims 1
- 229960002762 oxibendazole Drugs 0.000 claims 1
- 229950007337 parbendazole Drugs 0.000 claims 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 claims 1
- 229960000490 permethrin Drugs 0.000 claims 1
- 229960002957 praziquantel Drugs 0.000 claims 1
- QZWHWHNCPFEXLL-UHFFFAOYSA-N propan-2-yl n-[2-(1,3-thiazol-4-yl)-3h-benzimidazol-5-yl]carbamate Chemical compound N1C2=CC(NC(=O)OC(C)C)=CC=C2N=C1C1=CSC=N1 QZWHWHNCPFEXLL-UHFFFAOYSA-N 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- DDIQWGKUSJOETH-UHFFFAOYSA-N pyrafluprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SCF)=C1NCC1=CN=CC=N1 DDIQWGKUSJOETH-UHFFFAOYSA-N 0.000 claims 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 claims 1
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 claims 1
- AEHJMNVBLRLZKK-UHFFFAOYSA-N pyridalyl Chemical group N1=CC(C(F)(F)F)=CC=C1OCCCOC1=C(Cl)C=C(OCC=C(Cl)Cl)C=C1Cl AEHJMNVBLRLZKK-UHFFFAOYSA-N 0.000 claims 1
- MIOBBYRMXGNORL-UHFFFAOYSA-N pyrifluquinazon Chemical compound C1C2=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C2N(C(=O)C)C(=O)N1NCC1=CC=CN=C1 MIOBBYRMXGNORL-UHFFFAOYSA-N 0.000 claims 1
- ITKAIUGKVKDENI-UHFFFAOYSA-N pyrimidifen Chemical compound CC1=C(C)C(CCOCC)=CC=C1OCCNC1=NC=NC(CC)=C1Cl ITKAIUGKVKDENI-UHFFFAOYSA-N 0.000 claims 1
- 229960000948 quinine Drugs 0.000 claims 1
- 238000007363 ring formation reaction Methods 0.000 claims 1
- 229960002245 selamectin Drugs 0.000 claims 1
- AFJYYKSVHJGXSN-KAJWKRCWSA-N selamectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C(/C)=C/C[C@@H](O[C@]2(O[C@@H]([C@@H](C)CC2)C2CCCCC2)C2)C[C@@H]2OC(=O)[C@@H]([C@]23O)C=C(C)C(=N\O)/[C@H]3OC\C2=C/C=C/[C@@H]1C AFJYYKSVHJGXSN-KAJWKRCWSA-N 0.000 claims 1
- 229940014213 spinosad Drugs 0.000 claims 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 1
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 claims 1
- UPKCAVPJPFAJRR-XMMPIXPASA-N tert-butyl 6-[(5r)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC21C1=CC=C(C=3C[C@@](ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 UPKCAVPJPFAJRR-XMMPIXPASA-N 0.000 claims 1
- UPKCAVPJPFAJRR-DEOSSOPVSA-N tert-butyl 6-[(5s)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC21C1=CC=C(C=3C[C@](ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 UPKCAVPJPFAJRR-DEOSSOPVSA-N 0.000 claims 1
- MPLJXQMBXAYJDQ-UHFFFAOYSA-N tert-butyl 6-[3-(3,5-dichloro-4-fluorophenyl)-4,4,4-trifluorobut-2-enoyl]spiro[1H-2-benzofuran-3,3'-azetidine]-1'-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC21C1=CC=C(C(=O)C=C(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 MPLJXQMBXAYJDQ-UHFFFAOYSA-N 0.000 claims 1
- UPKCAVPJPFAJRR-UHFFFAOYSA-N tert-butyl 6-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CC21C1=CC=C(C=3CC(ON=3)(C=3C=C(Cl)C(F)=C(Cl)C=3)C(F)(F)F)C=C1CO2 UPKCAVPJPFAJRR-UHFFFAOYSA-N 0.000 claims 1
- GQZFZXWGEAPBCX-UHFFFAOYSA-N tert-butyl 6-acetylspiro[1h-2-benzofuran-3,3'-azetidine]-1'-carboxylate Chemical compound C=1C(C(=O)C)=CC=C2C=1COC21CN(C(=O)OC(C)(C)C)C1 GQZFZXWGEAPBCX-UHFFFAOYSA-N 0.000 claims 1
- 125000002053 thietanyl group Chemical group 0.000 claims 1
- 229960000323 triclabendazole Drugs 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Claims (19)
1. Spoj Formule (1)
[image]
,
naznačen time što
X je -O- i W je -CH2-;
svaki od R1a, R1b i R1c je neovisno vodik, halogen ili C1-C6halogenalkil;
R3 je C1-C6halogenalkil;
R4 je -C(O)R5;
R5 je C1-C6alkil, C0-C6alkilC3-C6Cikloalkil, C0-C6alkilheteroaril ili C0-C6alkilheterocikl;
gdje svaki od R5 ostataka C1-C6alkil ili C0-C6alkilC3-C6cikloalkil može biti izborno i neovisno supstituiran s najmanje jednim supstituentom, koji se bira između cijano, halogena, hidroksila, okso, C1-C6alkoksi, C1-C6halogenalkoksi, C1-C6halogenalkila, C1-C6alkila, hidroksilC1-C6alkil-, -S(O)pRc, -SH, -S(O)pNRaRb, -NRaRb, -NRaC(O)Rb, -SC(O)R, -SCN ili -C(O)NRaRb; te gdje svaki od R5 ostataka C0-C6alkilheteroaril ili C0-C6alkilheterocikl može biti dodatno izborno supstituiran s najmanje jednim supstituentom, koji se bira između cijano, halogena, okso, =S, =NR7, hidroksila, C1-C6alkoksi, C1-C6alkila, C1-C6halogenalkila, hidroksilC1-C6alkil-, -SH, -S(O)pR, te C1-C6halogenalkoksi;
R7 je vodik, C1-C6alkil, hidroksil, cijano, nitro, -S(O)pRc ili C1-C6alkoksi;
R je C1-C6alkil ili C3-C6cikloalkil, izborno supstituiran s najmanje jednim halogenim supstituentom;
Ra je vodik, C1-C6alkil ili C0-C3alkilC3-C6cikloalkil; gdje su alkil i alkilcikloalkil izborno supstituirani s cijano ili najmanje jednim halogenim supstituentom;
Rb je vodik, C1-C6alkil, C3-C6cikloalkil, C0-C3alkilfenil, C0-C3alkilheteroaril ili C0-C3alkilheterocikl, od kojih je svaki izborno supstituiran, gdje je to kemijski moguće, s najmanje jednim supstituentom, koji se bira između hidroksila, cijano, halogena ili -S(O)pR;
Rc je C1-C6alkil, C1-C6halogenalkil, C1-C6halogenalkilC3-C6cikloalkil, C0-C3alkilC3-C6cikloalkil, C0-C3alkilfenil, C0-C3alkilheteroaril ili C0-C3alkilheterocikl, od kojih je svaki izborno supstituiran s najmanje jednim supstituentom, koji se bira između cijano, halogena, hidroksila, okso, C1-C6alkoksi, C1-C6halogenalkoksi, C1-C6halogenalkila, -S(O)pR, -SH, -S(O)pNRaRb, -NRaRb, -NRaC(O)Rb, -SC(O)R, -SCN ili -C(O)NRaRb;
p je cijeli broj 0, 1 ili 2; i
n je cijeli broj 0;
njegovi stereoizomeri, te njegove veterinarski prihvatljive soli.
2. Spoj u skladu s patentnim zahtjevom 1, naznačen time što je R3 -CF3;
njegovi stereoizomeri, te njegove veterinarski prihvatljive soli.
3. Spoj u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što se bira iz skupine koju čine
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-((trifluormetil)tio)etanon;
(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(1-oksidotietan-3-il)metanon;
(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(1,1-dioksidotietan-3-il)metanon;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metiltio)etanon;
(R)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metiltio)etanon;
(S)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metiltio)etanon;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfinil)etanon;
(R)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfinil)etanon;
(S)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfinil)etanon;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
(R)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
(S)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-metilpropan-1-on;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-hidroksietanon;
ciklobutil(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)metanon;
(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(1-hidroksiciklopropil)metanon;
N-(2-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-oksoetil)formamid;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)etanon;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)propan-1-on;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-hidroksi-2-metilpropan-1-on;
2-ciklopropil-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)etanon;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2,2-dimetilpropan-1-on;
(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(1-(trifluormetil)ciklopropil)metanon;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-3-hidroksi-2-metilpropan-1-on;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(3-metil-1H-pirazol-1-il)etanon;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-3-metilbutan-1-on;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(1H-pirazol-1-il)etanon;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-3-hidroksibutan-1-on;
ciklopropil(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)metanon;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)butan-1-on;
(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(tietan-3-il)metanon;
(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(1,1-dioksidotietan-3-il)metanon;
(R)-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(1,1-dioksidotietan-3-il)metanon;
(S)-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(1,1-dioksidotietan-3-il)metanon;
2-(metilsulfonil)-1-(5′-(5-(3,4,5-triklorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)etanon;
1-(5′-(5-(3,5-diklorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
1-(5′-(5-(3-klor-5-(trifluormetil)fenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
1-(5′-(5-(3,4-diklor-5-(trifluormetil)fenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
1-(5′-(5-(4-brom-3,5-diklorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
1-(5′-(5-(3,5-bis(trifluormetil)fenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
(R)-1-(5′-(5-(3,5-bis(trifluormetil)fenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
(S)-1-(5′-(5-(3,5-bis(trifluormetil)fenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
1-(5′-(5-(3-brom-5-klorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
1-(5′-(5-(4-klor-3,5-bis(trifluormetil)fenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
1-(5′-(5-(3-klor-5-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
1-(5′-(5-(3-klor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
(R)-1-(5′-(5-(3-klor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
(S)-1-(5′-(5-(3-klor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanon;
2-(metilsulfonil)-1-(5′-(5-(trifluormetil)-5-(3-(trifluormetil)fenil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)etanon;
(R)-2-(metilsulfonil)-1-(5′-(5-(trifluormetil)-5-(3-(trifluormetil)fenil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)etanon; i
(S)-2-(metilsulfonil)-1-(5′-(5-(trifluormetil)-5-(3-(trifluormetil)fenil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)etanon,
ili njihovi stereoizomeri, ili njihove veterinarski prihvatljive soli.
4. Spoj u skladu s patentnim zahtjevom 3, naznačen time što se bira između:
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metiltio)etanona;
(R)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metiltio)etanona;
(S)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metiltio)etanona;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfinil)etanona;
(R)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfinil)etanona;
(S)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfinil)etanona;
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona;
(R)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona;
(S)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona;
(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(1,1-dioksidotietan-3-il)metanona;
(R)-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(1,1-dioksidotietan-3-il)metanona;
(S)-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)(1,1-dioksidotietan-3-il)metanona;
1-(5′-(5-(3,5-bis(trifluormetil)fenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona;
(R)-1-(5′-(5-(3,5-bis(trifluormetil)fenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona;
(S)-1-(5′-(5-(3,5-bis(trifluormetil)fenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona;
1-(5′-(5-(3-klor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona;
(R)-1-(5′-(5-(3-klor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona;
(S)-1-(5′-(5-(3-klor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona;
2-(metilsulfonil)-1-(5′-(5-(trifluormetil)-5-(3-(trifluormetil)fenil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)etanona;
(R)-2-(metilsulfonil)-1-(5′-(5-(trifluormetil)-5-(3-(trifluormetil)fenil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)etanona; i
(S)-2-(metilsulfonil)-1-(5′-(5-(trifluormetil)-5-(3-(trifluormetil)fenil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)etanona,
ili njihovih stereoizomera, ili njihovih veterinarski prihvatljivih soli.
5. Spoj u skladu s patentnim zahtjevom 4, naznačen time što se bira između:
1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona i
(S)-1-(5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-il)-2-(metilsulfonil)etanona.
6. Farmaceutski ili veterinarski pripravak, naznačen time što sadrži spoj u skladu s bilo kojim od patentnih zahtjeva 1 do 5.
7. Farmaceutski ili veterinarski pripravak u skladu s patentnim zahtjevom 6, naznačen time što dodatno sadrži veterinarski prihvatljivu pomoćnu tvar, razrjeđivač ili podlogu.
8. Veterinarski pripravak u skladu s patentnim zahtjevom 6 ili 7, naznačen time što dodatno sadrži najmanje jedno dodatno veterinarsko sredstvo.
9. Veterinarski pripravak u skladu s patentnim zahtjevom 8, naznačen time što se navedeno dodatno veterinarsko sredstvo bira iz skupine koju čine abamektin, ivermektin, avermektin, moksidektin, emamektin, eprinomektin, selamektin, doramektin, nemadektin, albendazol, kambendazol, fenbendazol, flubendazol, mebendazol, oksfenbendazol, oksibendazol, parbendazol, tetramisol, levamisol, pirantel-pamoat, oksantel, morantel, indoksakarb, klosantel, triklabendazol, klorsulon, refoksanid, niklosamid, prazikvantel, epsiprantel, 2-dezoksoparaherkvamid, piripol, pirafluprol, lufenuron, spiromesifen, tebufenozid, spinosad, spinetoram, imidakloprid, dinotefuran, metaflumizon, tibendiamid, klorantraniliprol, indoksakarb, piridalil, pirimidifen, piriflukinazon, milbemicin-oksim, milbemicin, demiditraz, amitraz, fipronil, metopren, hidropren, kinopren, permetrin, te piretrin, ili njihove smjese.
10. Veterinarski pripravak u skladu s patentnim zahtjevom 8, naznačen time što se navedeno dodatno veterinarsko sredstvo bira iz skupine koju čine moksidektin, pirantel-pamoat, milbemicin, milbemicin-oksim ili njihove smjese.
11. Spoj u skladu s bilo kojim od patentnih zahtjeva 1 do 5, naznačen time što je namijenjen upotrebi u liječenju parazitske infekcije ili infestacije kod životinje.
12. Spoj namijenjen upotrebi u skladu s patentnim zahtjevom 11, naznačen time što se spoj primjenjuje topikalno, oralno ili supkutano.
13. Spoj namijenjen upotrebi u skladu s patentnim zahtjevom 11, naznačen time što je navedena životinja domaća životinja.
14. Postupak priprave spoja Formule (63)
[image]
,
gdje
svaki od R1a, R1b i R1c je neovisno vodik, halogen ili C1-C6halogenalkil;
R5 je C1-C6alkil, C0-C6alkilC3-C6cikloalkil, C0-C6alkilheteroaril ili C0-C6alkilheterocikl;
R7 je vodik, C1-C6alkil, hidroksil, cijano, nitro, -S(O)pRc ili C1-C6alkoksi;
R je C1-C6alkil ili C3-C6cikloalkil, izborno supstituiran s najmanje jednim halogenim supstituentom;
Ra je vodik, C1-C6alkil ili C0-C3alkilC3-C6cikloalkil; gdje su alkil i alkilcikloalkil izborno supstituirani s cijano ili najmanje jednim halogenim supstituentom;
R5 je vodik, C1-C6alkil, C3-C6cikloalkil, C0-C3alkilfenil, C0-C3alkilheteroaril ili C0-C3alkilheterocikl, od kojih je svaki izborno supstituiran, gdje je to kemijski moguće, s najmanje jednim supstituentom, kojeg se bira između hidroksila, cijano, halogena ili -S(O)pR;
Rc je C1-C6alkil, C1-C6halogenalkil, C1-C6halogenalkilC3-C6cikloalkil, C0-C3alkilc3-C6cikloalkil, C0-C3alkilfenil, C0-C3alkilheteroaril ili C0-C3alkilheterocikl, od kojih je svaki izborno supstituiran s najmanje jednim supstituentom, koji se bira između cijano, halogena, hidroksila, okso, C1-C6alkoksi, C1-C6halogenalkoksi, C1-C6halogenalkila, -S(O)pR, -SH, -S(O)pNRaRb, -NRaRb, -NRaC(O)Rb, -SC(O)R, -SCN ili -C(O)NRaRb;
gdje R5 ostatak C1-C6alkil ili C0-C6alkilC3-C6cikloalkil može biti izborno i neovisno supstituiran s najmanje jednim supstituentom, koji se bira između cijano, halogena, hidroksila, okso, C1-C6alkoksi, C1-C6halogenalkoksi, C1-C6halogenalkila, C1-C6alkila, hidroksilC1-C6alkil-, -S(O)pRc, -SH, -S(O)pNRaRb, -NRaRb, -NRaC(O)Rb, -SC(O)R, -SCN ili -C(O)NRaRb; i
gdje R5 ostatak C0-C6alkilheteroaril ili C0-C6alkilheterocikl može biti dodatno izborno supstituiran s najmanje jednim supstituentom, koji se bira između cijano, halogena, okso, =S, =NR7, hidroksila, hidroksilC1-C6alkil-, C1-C6alkoksi, C1-C6alkila, C1-C6halogenalkila, -SH, -S(O)pR, te C1-C6halogenalkoksi;
n je cijeli broj 0;
p je cijeli broj 0, 1, ili 2; i
* opisuje kiralni centar,
njegovi stereoizomeri, te njegove veterinarski prihvatljive soli;
naznačen time što se navedeni postupak sastoji u, izborno u otapalu,
a) metalaciji jodbrombenzilnog derivata Formule 57 Grignardovim reagensom ili halogen-metalnom izmjenom s alkillitijem i reakciji sa zaštićenim azetidinonom u postupku u jednoj posudi ili u postupku u više koraka kako bi se dobilo spoj Formule 58, gdje je Y2 brom, klor, jod, hidroksil ili sulfonat kao izlazna skupina;
[image]
b) kondenzaciji spoja Formule 58 s vinil-eterom kataliziranoj paladijem kako bi se dobilo spoj Formule 59, gdje je R8 C1-C6alkil;
[image]
c) kondenzaciji spoja Formule 59 sa supstituiranim trifluoracetofenonom Formule 56 kako bi se dobilo spoj Formule 60;
[image]
d) dodavanju hidroksilamina spoju Formule 60 i ciklizacije u prisutnosti kiralnog katalizatora na bazi kinina kako bi se dobilo spoj Formule 61;
[image]
e) uklanjanju zaštitne skupine za azetidin iz spoja Formule 61 kako bi se dobilo spoj Formule 62; i
[image]
f) kondenziranju spoja Formule 62 s kiselinom ili kiselinskim kloridom u standardnim uvjetima za dobivanje amida kako bi se dobilo spoj Formule 63
[image]
.
15. Postupak u skladu s patentnim zahtjevom 14, naznačen time što
R5 ostatak C1-C6alkil ili C0-C6alkilC3-C6cikloalkil može biti izborno i neovisno supstituiran s najmanje jednim supstituentom, koji se bira između halogena, hidroksila, hidroksilC1-C6alkil-, C1-C6halogenalkil, C1-C6alkil ili -S(O)pRc; i
gdje R5 ostatak C0-C6alkilheteroaril ili C0-C6alkilheterocikl može biti dodatno izborno supstituiran s najmanje jednim supstituentom, koji se bira između okso, hidroksila, hidroksiC1-C6alkil-, C1-C6alkila ili C1-C6halogenalkila;
Rc je C1-C6alkil;
n je cijeli broj 0; i
p je cijeli broj 0, 1, ili 2;
njegovi stereoizomeri, te njegove veterinarski prihvatljive soli.
16. Postupak u skladu s patentnim zahtjevom 15, naznačen time što
svaki od R1a, R1b i R1c je neovisno vodik, klor, fluor, brom ili trifluormetil;
R5 je metil, etil, propil, izopropil, butil, izobutil, t-butil, ciklopropil ili ciklobutil, gdje svaki supstituent može biti izborno i neovisno supstituiran s najmanje jednim supstituentom, koji se bira između halogena, hidroksila, C1-C6halogenalkila, C1-C6alkila ili -S(O)pRc; ili je R5 tietanil, pirazolil ili -CH2pirazolil, gdje svaki supstituent može biti dodatno izborno supstituiran s najmanje jednim supstituentom, koji se bira između okso ili C1-C6alkila; i
Rc je metil ili etil;
njegovi stereoizomeri, te njegove veterinarski prihvatljive soli.
17. Postupak u skladu s patentnim zahtjevom 16, naznačen time što
svaki od R1a i R1c je klor, a R1b je fluor;
R5 je -CH2S(O)2CH3;
njegovi stereoizomeri, te njegove veterinarski prihvatljive soli.
18. Postupak u skladu s patentnim zahtjevom 14, naznačen time što se može provoditi u otapalu, gdje je jodbrombenzilni derivat 4-brom-2-(klormetil)-1-jodobenzen, a zaštićeni azetidinon je tert-butilni ester 3-oksoazetidin-1-karboksilne kiseline ili 1-benzhidrilazetidin-3-on.
19. Spoj, naznačen time što se bira iz skupine koju čine:
tert-butil-5′-brom-3′H-spiro[azetidin-3, ′-izobenzofuran]-1-karboksilat;
1-benzhidril-5′-brom-3′H-spiro[azetidin-3,1′-izobenzofuran];
tert-butil-5′-acetil-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-karboksilat;
1-(1-benzhidril-3′H-spiro[azetidin-3,1′-izobenzofuran]-5′-il)etanon;
tert-butil-5′-(3-(3,5-diklor-4-fluorfenil)-4,4,4-trifluorbut-2-enoil)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-karboksilat;
(R)-tert-butil-5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-karboksilat;
(S)-tert-butil-5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-karboksilat;
(E/Z)-1-(1-benzhidril-3′H-spiro[azetidin-3,1′-izobenzofuran]-5′-il)-3-(3,5-diklor-4-fluorfenil)-4,4,4-trifluorbut-2-en-1-on;
tert-butil-5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-1-karboksilat;
(R)-5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-para-toluensulfonat;
(S)-5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-para-toluensulfonat;
1-benzhidril-5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran];
(R)-1-benzhidril-5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran] (S)-1-benzhidril-5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]; i
5′-(5-(3,5-diklor-4-fluorfenil)-5-(trifluormetil)-4,5-dihidroizoksazol-3-il)-3′H-spiro[azetidin-3,1′-izobenzofuran]-para-toluensulfonat,
ili njihovi stereoizomeri.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161451256P | 2011-03-10 | 2011-03-10 | |
US201161489913P | 2011-05-25 | 2011-05-25 | |
US201161490804P | 2011-05-27 | 2011-05-27 | |
EP12709376.3A EP2683723B1 (en) | 2011-03-10 | 2012-02-23 | Spirocyclic isoxazoline derivatives as antiparasitic agents |
PCT/IB2012/050842 WO2012120399A1 (en) | 2011-03-10 | 2012-02-23 | Spirocyclic isoxazoline derivatives as antiparasitic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20160601T1 true HRP20160601T1 (hr) | 2016-07-01 |
Family
ID=45852624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20160601TT HRP20160601T1 (hr) | 2011-03-10 | 2016-06-03 | Spirociklički derivati izoksazolina kao antiparazitska sredstva |
Country Status (26)
Country | Link |
---|---|
US (1) | US8466115B2 (hr) |
EP (1) | EP2683723B1 (hr) |
JP (1) | JP5806743B2 (hr) |
KR (1) | KR101565853B1 (hr) |
CN (1) | CN103517907B (hr) |
AR (1) | AR085649A1 (hr) |
AU (1) | AU2012226475C1 (hr) |
BR (1) | BR112013023068B8 (hr) |
CA (1) | CA2828397C (hr) |
CL (1) | CL2013002516A1 (hr) |
CO (1) | CO6761337A2 (hr) |
CY (1) | CY1117987T1 (hr) |
ES (1) | ES2585555T3 (hr) |
HK (1) | HK1190393A1 (hr) |
HR (1) | HRP20160601T1 (hr) |
HU (1) | HUE029810T2 (hr) |
ME (1) | ME02412B (hr) |
MX (1) | MX2013010336A (hr) |
PL (1) | PL2683723T3 (hr) |
PT (1) | PT2683723T (hr) |
RS (1) | RS54860B1 (hr) |
RU (1) | RU2566083C3 (hr) |
SI (1) | SI2683723T1 (hr) |
UY (1) | UY33943A (hr) |
WO (1) | WO2012120399A1 (hr) |
ZA (1) | ZA201306817B (hr) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP2014007874A0 (en) * | 2012-02-06 | 2014-08-31 | Merial Ltd | Parasiticidal oral veterinary compositions comprising systemetically- acting active agents, methods and uses thereof |
JO3626B1 (ar) | 2012-02-23 | 2020-08-27 | Merial Inc | تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها |
AU2013308887B2 (en) * | 2012-08-31 | 2015-11-12 | Zoetis Services Llc | Crystalline forms of 1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'H-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone |
EP2900065A1 (en) | 2012-09-04 | 2015-08-05 | Zoetis LLC | Spirocyclic isoxazoline derivatives for treatment of sea lice |
US9131697B2 (en) | 2012-09-07 | 2015-09-15 | Zoetis Services Llc | Spirocyclic isoxazolines as antiparasitic agents |
KR101792370B1 (ko) * | 2012-09-07 | 2017-11-01 | 조에티스 서비시즈 엘엘씨 | 스피로환식 아이소옥사졸린 구충제 조합물 |
CA2881844A1 (en) | 2012-09-07 | 2014-03-13 | Zoetis Llc | Spirocyclic derivatives as antiparasitic agents |
EP2922854B1 (en) * | 2012-11-21 | 2022-05-04 | Zoetis Services LLC | Synthesis of spirocyclic isoxazoline derivatives |
MY172725A (en) | 2013-02-06 | 2019-12-11 | Vetoquinol Sa | Halogen-substituted pyrazol derivatives as pest-control agents |
US20160081986A1 (en) * | 2013-05-20 | 2016-03-24 | Zoetis Services Llc | Long-acting spiro-isoxazoline antiparasitic compositions |
US10350196B2 (en) | 2013-09-30 | 2019-07-16 | Zoetis Services Llc | Long-acting spiro-isoxazoline formulations |
US9371293B2 (en) | 2013-10-25 | 2016-06-21 | Sumitomo Chemical Company, Limited | Isoxazoline compound composition |
EP3063144B1 (en) | 2013-11-01 | 2021-09-08 | Boehringer Ingelheim Animal Health USA Inc. | Antiparasitic and pesticidal isoxazoline compounds |
EP3082867B1 (en) | 2013-12-20 | 2024-01-17 | Intervet International B.V. | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals |
EP3089972B1 (de) | 2014-01-03 | 2018-05-16 | Bayer Animal Health GmbH | Neue pyrazolyl-heteroarylamide als schädlingsbekämpfungsmittel |
ES2765405T3 (es) | 2014-04-17 | 2020-06-09 | Boehringer Ingelheim Animal Health Usa Inc | Utilización de compuestos de malononitrilo para proteger animales de parásitos |
TW201607938A (zh) | 2014-07-15 | 2016-03-01 | 拜耳作物科學股份有限公司 | 作為殺蟲劑之新穎芳基三唑基吡啶類 |
NZ731446A (en) | 2014-10-31 | 2018-09-28 | Boehringer Ingelheim Animal Health Usa Inc | Parasiticidal composition comprising fipronil |
CN106999475B (zh) * | 2014-12-22 | 2022-10-25 | 英特维特国际股份有限公司 | 异噁唑啉化合物用于治疗蠕形螨病的用途 |
MX370163B (es) * | 2015-01-16 | 2019-12-04 | Avista Pharma Solutions Inc | Compuestos antiparasitarios. |
UY36570A (es) | 2015-02-26 | 2016-10-31 | Merial Inc | Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas |
US20170020848A1 (en) | 2015-04-08 | 2017-01-26 | Merial Inc. | Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof |
HUE055535T2 (hu) | 2015-05-20 | 2021-12-28 | Boehringer Ingelheim Animal Health Usa Inc | Féreghajtó depszipeptid-vegyületek |
UY37137A (es) * | 2016-02-24 | 2017-09-29 | Merial Inc | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos |
US20190077809A1 (en) | 2016-03-09 | 2019-03-14 | Basf Se | Spirocyclic Derivatives |
BR112018068042A2 (pt) | 2016-03-11 | 2019-01-08 | Basf Se | métodos para controlar pragas de plantas, material de propagação de planta e uso de um ou mais compostos de fórmula i |
WO2017176948A1 (en) | 2016-04-06 | 2017-10-12 | Merial, Inc. | Process for the preparation of enantiomerically enriched isoxazoline compounds - crystalline toluene solvate of (s)-afoxolaner |
US10556909B2 (en) | 2016-05-20 | 2020-02-11 | Avista Pharma Solutions, Inc. | Synthetic process and intermediates |
WO2018009751A1 (en) * | 2016-07-08 | 2018-01-11 | Avista Pharma Solutions, Inc. | Antiparasitic compounds |
WO2018039508A1 (en) | 2016-08-25 | 2018-03-01 | Merial, Inc. | Method for reducing unwanted effects in parasiticidal treatments |
JP2019535655A (ja) | 2016-10-14 | 2019-12-12 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 殺虫性及び殺寄生虫性ビニルイソオキサゾリン化合物 |
WO2018093920A1 (en) | 2016-11-16 | 2018-05-24 | Merial, Inc. | Anthelmintic depsipeptide compounds |
WO2018162312A1 (en) * | 2017-03-10 | 2018-09-13 | Basf Se | Spirocyclic derivatives |
WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
EP3668866B1 (en) * | 2017-08-14 | 2023-01-18 | Boehringer Ingelheim Animal Health USA Inc. | Pesticidal and parasiticidal pyrazole-isoxazoline compounds |
JP7305620B2 (ja) | 2017-09-06 | 2023-07-10 | バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 動物寄生虫(animal parasites)の防除および予防のための局所投与製剤 |
WO2019099669A1 (en) * | 2017-11-16 | 2019-05-23 | Avista Pharma Solutions, Inc. | Single enantiomer antiparasitic compounds |
BR112020012018A2 (pt) | 2017-12-15 | 2020-11-24 | Tarsus Pharmaceuticals, Inc. | formulações de parasiticida de isoxazolina e métodos para tratar blefarite |
WO2019157241A1 (en) | 2018-02-08 | 2019-08-15 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof |
MX2020013291A (es) | 2018-06-07 | 2021-04-29 | Idorsia Pharmaceuticals Ltd | Derivados de piridinilo alcoxisustituido como antagonistas del receptor lpa1 y su uso en el tratamiento de la fibrosis. |
AU2019301510B2 (en) | 2018-07-09 | 2024-06-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anthelminthic heterocyclic compounds |
EP3873881A1 (en) | 2018-10-29 | 2021-09-08 | Basf Se | Process for preparation of optically enriched aldol compounds |
US20210380569A1 (en) | 2018-11-06 | 2021-12-09 | Basf Se | Process for Preparation of Optically Enriched Isoxazolines |
US11773066B2 (en) | 2018-11-20 | 2023-10-03 | Boehringer Ingelheim Animal Health USA Inc. | Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof |
BR112021009123A2 (pt) | 2018-12-04 | 2021-08-10 | Basf Se | processo para a preparação de 5-bromo-1,3-dicloro-2-fluoro-benzeno e processo para a preparação de composto de fórmula v |
WO2020150032A1 (en) | 2019-01-16 | 2020-07-23 | Boehringer Ingelheim Animal Health USA Inc. | Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof |
US11560388B2 (en) | 2019-03-19 | 2023-01-24 | Boehringer Ingelheim Vetmedica Gmbh | Anthelmintic aza-benzothiophene and aza-benzofuran compounds |
AR119162A1 (es) | 2019-06-18 | 2021-12-01 | Idorsia Pharmaceuticals Ltd | Derivados de piridin-3-ilo |
MX2022007455A (es) * | 2019-12-18 | 2022-08-15 | Elanco Tiergesundheit Ag | Derivados de isoxazolina como plaguicidas. |
CN111253331B (zh) * | 2020-03-17 | 2022-03-08 | 南京林业大学 | 一种以二氢查尔酮为原料合成螺异噁唑啉的方法 |
AU2021278871A1 (en) | 2020-05-28 | 2023-01-19 | Boehringer Ingelheim Animal Health USA Inc. | Bi-modal release intra-ruminal capsule device and methods of use thereof |
WO2021242581A1 (en) | 2020-05-29 | 2021-12-02 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic heterocyclic compounds |
CN111675668B (zh) * | 2020-06-28 | 2022-09-13 | 南京林业大学 | 一种tempo催化的以肟类化合物为原料合成螺异噁唑啉的反应方法 |
CA3205997A1 (en) | 2020-12-21 | 2022-06-30 | University Of Georgia Research Foundation Inc. | Parasiticidal collar comprising isoxazoline compounds |
US20240116854A1 (en) | 2021-01-27 | 2024-04-11 | Intervet Inc. | Cyclopropylamide compounds against parasites in fish |
BR112023015168A2 (pt) | 2021-01-27 | 2023-10-03 | Corteva Agriscience Llc | Compostos de ciclopropilamida contra parasitas em peixes |
JP2024516912A (ja) | 2021-05-14 | 2024-04-17 | シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト | 昆虫、ダニ目及び線虫有害生物の防除 |
CA3223820A1 (en) | 2021-06-16 | 2022-12-22 | Elanco Tiergesundheit Ag | Isoxazoline pesticides |
CA3222495A1 (en) | 2021-06-16 | 2022-12-22 | Elanco Tiergesundheit Ag | (thi)oxazoline pesticides |
WO2022268813A1 (en) | 2021-06-24 | 2022-12-29 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
WO2022268815A1 (en) | 2021-06-24 | 2022-12-29 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
WO2023046853A1 (en) | 2021-09-23 | 2023-03-30 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
WO2023156938A1 (en) | 2022-02-17 | 2023-08-24 | Boehringer Ingelheim Vetmedica Gmbh | Method and system for providing a fluid product mailer |
WO2023203038A1 (en) | 2022-04-19 | 2023-10-26 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
FI20225388A1 (en) | 2022-05-05 | 2023-11-06 | Equinorm Ltd | New heterocyclic compounds, preparation methods and their uses |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554753A (en) | 1993-08-25 | 1996-09-10 | Indiana University Foundation | Catalytic enantioselective synthesis of α-amino acid derivatives by phase-transfer catalysis |
TW524667B (en) | 1996-12-05 | 2003-03-21 | Pfizer | Parasiticidal pyrazoles |
GB0329314D0 (en) | 2003-12-18 | 2004-01-21 | Pfizer Ltd | Substituted arylpyrazoles |
EA014881B1 (ru) * | 2004-03-05 | 2011-02-28 | Ниссан Кемикал Индастриз, Лтд. | Производные замещенного алкилбензола |
WO2007006688A1 (en) | 2005-07-14 | 2007-01-18 | F. Hoffmann-La Roche Ag | Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
TW200803740A (en) | 2005-12-16 | 2008-01-16 | Du Pont | 5-aryl isoxazolines for controlling invertebrate pests |
DE602007006288D1 (de) * | 2006-03-10 | 2010-06-17 | Nissan Chemical Ind Ltd | Substituierte isoxazolin-verbindung und schädlingsbekämpfungsmittel |
US8575167B2 (en) | 2007-02-06 | 2013-11-05 | Takeda Pharmaceutical Company Limited | Spiro compounds having stearoyl-CoA desaturase action |
WO2008122375A2 (en) | 2007-04-10 | 2008-10-16 | Bayer Cropscience Ag | Insecticidal aryl isoxazoline derivatives |
JP5184057B2 (ja) * | 2007-08-10 | 2013-04-17 | 日本曹達株式会社 | 含窒素複素環化合物および有害生物防除剤 |
KR20100064382A (ko) | 2007-09-10 | 2010-06-14 | 닛산 가가쿠 고교 가부시키 가이샤 | 치환 이속사졸린 화합물 및 유해생물 방제제 |
JP5365807B2 (ja) | 2007-11-12 | 2013-12-11 | 日産化学工業株式会社 | 光学活性イソキサゾリン化合物の触媒的不斉合成方法 |
JP2009286773A (ja) * | 2008-03-14 | 2009-12-10 | Bayer Cropscience Ag | 殺虫性縮環式アリール類 |
US8686014B2 (en) | 2008-09-04 | 2014-04-01 | Syngenta Limited | Insecticidal compounds |
WO2010027051A1 (ja) * | 2008-09-04 | 2010-03-11 | 日産化学工業株式会社 | 置換アセトフェノン化合物、その製造方法及び用途 |
KR20110042231A (ko) | 2008-09-18 | 2011-04-25 | 닛뽕소다 가부시키가이샤 | 함질소 복소 고리 화합물 및 유해 생물 방제제 |
WO2010084067A2 (en) | 2009-01-22 | 2010-07-29 | Syngenta Participations Ag | Insecticidal compounds |
JP2013520456A (ja) | 2010-02-25 | 2013-06-06 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | イソオキサゾリン誘導体の製造方法 |
-
2012
- 2012-02-23 JP JP2013557191A patent/JP5806743B2/ja active Active
- 2012-02-23 RU RU2013139630A patent/RU2566083C3/ru active
- 2012-02-23 CA CA2828397A patent/CA2828397C/en active Active
- 2012-02-23 CN CN201280022404.XA patent/CN103517907B/zh active Active
- 2012-02-23 WO PCT/IB2012/050842 patent/WO2012120399A1/en active Application Filing
- 2012-02-23 PL PL12709376T patent/PL2683723T3/pl unknown
- 2012-02-23 MX MX2013010336A patent/MX2013010336A/es active IP Right Grant
- 2012-02-23 BR BR112013023068A patent/BR112013023068B8/pt active IP Right Grant
- 2012-02-23 HU HUE12709376A patent/HUE029810T2/en unknown
- 2012-02-23 ES ES12709376.3T patent/ES2585555T3/es active Active
- 2012-02-23 AU AU2012226475A patent/AU2012226475C1/en active Active
- 2012-02-23 PT PT127093763T patent/PT2683723T/pt unknown
- 2012-02-23 EP EP12709376.3A patent/EP2683723B1/en active Active
- 2012-02-23 ME MEP-2016-125A patent/ME02412B/me unknown
- 2012-02-23 RS RS20160432A patent/RS54860B1/sr unknown
- 2012-02-23 SI SI201230583A patent/SI2683723T1/sl unknown
- 2012-02-23 KR KR1020137026527A patent/KR101565853B1/ko active Protection Beyond IP Right Term
- 2012-03-08 US US13/414,764 patent/US8466115B2/en active Active
- 2012-03-09 UY UY0001033943A patent/UY33943A/es active IP Right Grant
- 2012-03-09 AR ARP120100780A patent/AR085649A1/es active IP Right Grant
-
2013
- 2013-08-30 CL CL2013002516A patent/CL2013002516A1/es unknown
- 2013-09-06 CO CO13211877A patent/CO6761337A2/es unknown
- 2013-09-10 ZA ZA2013/06817A patent/ZA201306817B/en unknown
-
2014
- 2014-04-10 HK HK14103441.3A patent/HK1190393A1/zh unknown
-
2016
- 2016-06-03 HR HRP20160601TT patent/HRP20160601T1/hr unknown
- 2016-07-22 CY CY20161100723T patent/CY1117987T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20160601T1 (hr) | Spirociklički derivati izoksazolina kao antiparazitska sredstva | |
AU2011287323B2 (en) | Isoxazoline derivatives as antiparasitic agents | |
JP3297185B2 (ja) | 除草剤 | |
US9131697B2 (en) | Spirocyclic isoxazolines as antiparasitic agents | |
CA2794428A1 (en) | Substituted 3,5-diphenyl-isoxazoline derivatives as insecticides and acaricides | |
EP2900645A1 (de) | Herbizid wirksame 3-phenylisoxazolinderivate | |
AU2013259847B2 (en) | Azetidine derivatives as antiparasitic agents | |
EP2814825B1 (en) | Dihydrofuran azetidine derivatives as antiparasitic agents | |
WO2000024722A1 (en) | 2,3-dihydro-4-oxo-4h-1,3-oxazine and 2-oxo-1,2,5,6-tetrahydropyridine derivatives and their use as herbicides | |
NZ614547B2 (en) | Spirocyclic isoxazoline derivatives as antiparasitic agents |